Indaptus Therapeutics, Inc.
NASDAQIndaptus Therapeutics heads into its May 11 Q1 earnings with the stock in freefall, short interest at a multi-month high, and a director having just unloaded more than $10 million in shares. The week's price action is the first thing to reckon with. INDP closed at $2.14 on Friday — a 24% single-session drop on May 1, and down 35% across the week. The one-month picture is slightly…
Snapshot as of 8 May 2026
Indaptus Therapeutics heads into its May 11 Q1 earnings with the stock in freefall, short interest at a multi-month high, and a director having just unloaded more than $10 million in shares. The week's price action is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INDP — free to start on ORTEX.
Sign up for free →Open INDP on ORTEX